Beyond the Headlines, Columns-Drugs & Supplements, November 2005

October 26, 2005

J&J Purchases Guidant for $21.5 Billion NEW BRUNSWICK, N.J. - Johnson & Johnson revised its agreement with Guidant Corp. and will acquire the company for $21.5 billion, $3.9 billion less than what was previously offered, J&J announced on Nov. 15. The companies revised their agreement after J&J said that recent defibrillator and pacemaker recalls had a 'material adverse effect on Guidant' and said it was unsure whether it would complete the merger. J&J and Guidant originally entered into an agreement in December 2004. The transaction has an estimated net acquisition cost of $19 billion based … Subscribe Now Purchase Article for $40.00 Registered User Log In Email Address Password Login Forgot your username or password? UPCOMING CONFERENCES HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates May 29, 2024 - Salt Lake City, UT The Grand America Hotel MORE DETAILS HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone June 27, 2024 - Buffalo, NY The Richardson Hotel Buffalo MORE DETAILS Sign Up For Email Alerts × Email address Publications Asbestos Benzene & Emerging Toxic Torts Litigation Camp Lejeune & Water Contamination Drugs & Medical Devices MDL Mass Tort & Class Action Monitor Reinsurance & Arbitration Talcum Powder Litigation Report Close Submit